Beta-O2 is developing the ßAir Bio-artificial Pancreas, intended to cure Type 1 diabetes (TID).
Location: Israel, Center District, Rosh HaAyin
Employees: 11-50
Phone: +972 3-918-0700
Total raised: $1M
Founded date: 2004
Investors 3
| Date | Name | Website |
| - | Sherpa Inn... | sherpa-inn... |
| - | Aurum Vent... | aurum.co.i... |
| - | Southern I... | sibf.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.09.2021 | - | $1M | - |
Mentions in press and media 1
| Date | Title | Description |
| 30.03.2015 | Beta-O2 Technologies Receives Investment from Sherpa Innoventures | Beta-O2 Technologies, a Rosh Ha’ayin, Israel-based biomedical company, received an investment from Sherpa Innoventures. The amount of the deal was not disclosed. The new funding will be used to accelerate the company’s clinical development ... |